Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHC
3076
Diversified Healthcare Trust
DHC
$2.15B
| $1.36M | ﹤0.01% |
324,514
+245,405
| +310% | +$827K |
|
3077
CALL
Lamb Weston
LW
$7.22B
| $1.36M | ﹤0.01% |
21,000
| – | – |
|
3078
Burke & Herbert Financial Services Corp
BHRB
$1.48B
| $1.36M | ﹤0.01% |
22,225
+14,915
| +204% | +$914K |
|
3079
International Money Express
IMXI
$357M
| $1.35M | ﹤0.01% |
73,260
+42,367
| +137% | +$809K |
|
3080
Gorman-Rupp
GRC
$2.14B
| $1.35M | ﹤0.01% |
34,777
+26,455
| +318% | +$1.02M |
|
3081
SI-BONE Inc
SIBN
$788M
| $1.35M | ﹤0.01% |
96,623
+63,402
| +191% | +$954K |
|
3082
Koppers
KOP
$943M
| $1.35M | ﹤0.01% |
36,941
+28,855
| +357% | +$1.08M |
|
3083
Rush Enterprises Class B
RUSHB
$6.04B
| $1.35M | ﹤0.01% |
28,082
+9,981
| +55% | +$451K |
|
|
AD
3084
Array Digital Infrastructure
AD
$3.01B
| $1.35M | ﹤0.01% |
24,636
+2,405
| +11% | +$132K |
|
3085
ImmunityBio
IBRX
$7.51B
| $1.34M | ﹤0.01% |
361,036
+202,248
| +127% | +$936K |
|
|
ETWO
3086
DELISTED
E2open Parent Holdings
ETWO
| $1.34M | ﹤0.01% |
303,515
+240,858
| +384% | +$1.05M |
|
3087
Sturm, Ruger & Co
RGR
$594M
| $1.34M | ﹤0.01% |
32,097
+22,770
| +244% | +$961K |
|
3088
CALL
Moderna
MRNA
$21.8B
| $1.34M | ﹤0.01% |
20,000
-252,700
| -93% | -$23.2M |
|
|
3089
PUT
Moderna
MRNA
$21.8B
| $1.34M | ﹤0.01% |
+20,000
| New | +$1.84M |
|
3090
First Mid Bancshares
FMBH
$1.39B
| $1.34M | ﹤0.01% |
34,347
+26,315
| +328% | +$994K |
|
|
EU
3091
enCore Energy
EU
$212M
| $1.33M | ﹤0.01% |
329,730
-126,319
| -28% | -$468K |
|
|
SHOE
3092
Shoe Station Group
SHOE
$413M
| $1.33M | ﹤0.01% |
30,342
+19,868
| +190% | +$811K |
|
3093
Bausch Health
BHC
$2.58B
| $1.33M | ﹤0.01% |
162,772
-59,019
| -27% | -$389K |
|
3094
Sana Biotechnology
SANA
$871M
| $1.33M | ﹤0.01% |
318,910
+178,179
| +127% | +$936K |
|
3095
Scholar Rock
SRRK
$5.67B
| $1.33M | ﹤0.01% |
165,449
+84,118
| +103% | +$739K |
|
3096
PUT
Fastly Inc
FSLY
$3.55B
| $1.32M | ﹤0.01% |
+175,000
| New | +$1.21M |
|
3097
Scholastic
SCHL
$767M
| $1.32M | ﹤0.01% |
41,228
+30,699
| +292% | +$980K |
|
3098
PUT
ResMed
RMD
$30.6B
| $1.32M | ﹤0.01% |
+5,400
| New | +$1.21M |
|
|
PETQ
3099
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.32M | ﹤0.01% |
42,805
-52,977
| -55% | -$1.43M |
|
|
SNCY
3100
DELISTED
Sun Country Airlines
SNCY
| $1.32M | ﹤0.01% |
117,457
+84,906
| +261% | +$958K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.